In April 2026, NASA’s Office of the Chief Medical and Health Officer (OCHMO) initiated a working group to review updated VTE case information, additional data collected revealing altered blood flow status within a cohort of astronauts, and discuss the progress of research and clinical activities aimed at mitigating the risk of VTE during spaceflight with